echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The New Deal has landed!

    The New Deal has landed!

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On May 10, the National Medical Insurance Administration issued a notice stating that in order to ensure the smooth implementation of the negotiated drugs for the National Medical Insurance (referred to as the negotiated drugs), improve their guaranteed supply level, and better meet the reasonable drug needs of the insured patients, it was issued in conjunction with the Health Commission.
    "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for Drugs in National Medical Insurance Negotiations"
    .


    "Dual channel" refers to the mechanism that meets reasonable needs for negotiating drug supply guarantees and clinical use through two channels, designated medical institutions and designated retail pharmacies, and simultaneously incorporates them into the medical insurance payment mechanism


    The "Guiding Opinions" is divided into seven parts, respectively, in terms of classified management, selection of pharmacies, standardized use, improvement of payment policies, optimization of handling management, strengthening of supervision, and strengthening of leadership, etc.
    , and put forward requirements for the "dual channel" management of negotiated drugs
    .


    The purpose of issuing the "Guiding Opinions" is to take advantage of the flexible and widely distributed services of designated retail pharmacies, include them in the scope of negotiated drug supply guarantees, increase drug supply channels and patient medication options, and promote designated retail pharmacies to improve service quality and improve negotiation Access to medicines


    For the first time, the "Guiding Opinions" included designated retail pharmacies at the national level into the scope of the supply of medical insurance drugs, and implemented a unified payment policy with medical institutions
    .


    The promulgation of the "Guiding Opinions" marks a step towards diversification in the supply of negotiated drugs.


    Source: National Medical Insurance Administration

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.